Literature DB >> 32184051

Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations.

Jae Baek1, Dwight H Owen2, Robert E Merritt3, Konstantin Shilo4, Gregory A Otterson2, Desmond M D'Souza3, David P Carbone2, Peter J Kneuertz5.   

Abstract

Entities:  

Keywords:  Immune checkpoint therapy; Immunotherapy; Lobectomy; Minimally invasive; Non–small-cell lung cancer

Mesh：

Substances：

Year:  2020        PMID： 32184051     DOI： 10.1016/j.cllc.2020.02.016

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  2 in total

1.  Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient.

Authors:  Shinkichi Takamori; Mitsuhiro Takenoyama; Taichi Matsubara; Takatoshi Fujishita; Kensaku Ito; Masafumi Yamaguchi; Ryo Toyozawa; Takashi Seto; Tatsuro Okamoto
Journal:  Thorac Cancer       Date:  2020-10-16       Impact factor: 3.500

2.  Thoracoscopic intrapericardial lingular segmentectomy for advanced lung cancer following immunotherapy.

Authors:  Andre Chou; Shah Hwa Chou; Yu-Wei Liu
Journal:  Thorac Cancer       Date:  2021-03-16       Impact factor: 3.500
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.